Actualités 17. Apr. 2024 Addex Therapeutics lance la spin-off Neurosterix à Genève avec un investissement de USD 63 millions La société genevoise Addex Therapeutics s’est associée à Perceptive Advisors pour lancer la spin-off Neurosterix, un nouvel acteur dans le dévelo...
Actualités 30. Apr. 2024 Les Grands Titres de Suisse occidentale (Avril 2024) De percées biotechnologiques à la transformation des essais cliniques, en passant par des avancées dans le domaine des matériaux écologiques et d...
News 17. Apr. 2024 Addex Therapeutics launches spin-off Neurosterix in Geneva with USD 63 million investment Geneva's Addex Therapeutics has teamed up with Perceptive Advisors to launch spin-off Neurosterix, a new player in neurology-focused drug develop...
Actualités 16. Apr. 2024 OPEO a officiellement lancé sa première filiale internationale à Lausanne Le spécialiste français de la performance industrielle OPEO a célébré le lancement de sa première filiale internationale au SwissTech Convention ...
News 06. Mai 2024 EY reports growth of 53 percent for investments in Switzerland Foreign investments in Europe fell by 4 percent in 2023. However, investments in Switzerland were up by 53 percent. These findings were reported ...
Aktuell 14. Febr. 2024 Tessin erhält Innovation Booster für Mode und Lifestyle Die Stadt Lugano, Dagorà Lifestyle Innovation Hub und der Switzerland Innovation Park Ticino haben gemeinsam ein Innovation Booster Programm für ...
News 30. Apr. 2024 Top Stories from Western Switzerland (April 2024) From biotech breakthroughs and the transformation of clinical trials to advancements in eco-friendly materials and renewable energy initiatives, ...
News 14. Febr. 2024 Ticino receives Innovation Booster for fashion and lifestyle The city of Lugano, Dagorà Lifestyle Innovation Hub and Switzerland Innovation Park Ticino have initiated an innovation booster program for fashi...
News 16. Apr. 2024 OPEO has officially launched its first international subsidiary in Lausanne French industrial performance specialist OPEO has celebrated the launch of its first international subsidiary at EPFL’s SwissTech Convention Cent...
Aktuell 20. Okt. 2023 Xlife Sciences wird Hauptaktionär von 4D Lifetec Xlife Sciences, ein börsennotierter Beschleuniger und Investor für innovative Gesundheitslösungen, beteiligt sich mit 23,3 Millionen Franken an d...
News 20. Okt. 2023 Xlife Sciences becomes main shareholder in 4D Lifetec Xlife Sciences, a listed accelerator and investor in innovative healthcare solutions, has made an investment totalling 23.3 million Swiss francs ...
News 07. Aug. 2023 CDR-Life receives milestone payment CDR-Life has reached a second milestone linked to the development of its drug to combat an irreversible retinal disease. This entitles the biotec...
Aktuell 07. Aug. 2023 CDR-Life erhält Meilensteinzahlung CDR-Life hat bei der Entwicklung seines Therapeutikums gegen eine irreversible Erkrankung der Netzhaut ein zweites Etappenziel erreicht. Das bere...
News 25. Okt. 2023 Mecaplast Swiss, 50 years of innovation in the canton of Fribourg With a rich history spanning five decades, Mecaplast Swiss has consistently proven itself as a leader in the plastic injection industry, particul...
News 10. Jan. 2024 The remarkable chemical-pharmaceutical industry in the canton of Valais For decades, the canton of Valais has cultivated a reputation for excellence in the chemical and pharmaceutical industries, combining innovation ...
News 20. März 2024 Spineart raises CHF 20 million to push the boundaries of spinal surgery Spineart, the Geneva-based pioneer in spinal surgery innovations, has successfully secured over CHF 20 million in convertible financing.
News 19. Dez. 2023 Socorex wins CSEM’s prestigious Digital Journey Award 2023 Socorex, a leader in precision dosing instruments, has won the CSEM’s Digital Journey Award 2023, for its digital innovation in animal health.
News 14. Aug. 2023 Bern’s thriving ecosystem for life sciences innovation In the heart of Western Switzerland, the canton of Bern has emerged as a location of choice for companies in the life sciences sector.